188 related articles for article (PubMed ID: 18549897)
1. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
Emani S; Zhang J; Guo L; Guo H; Kuo PC
Surgery; 2008 Jun; 143(6):803-12. PubMed ID: 18549897
[TBL] [Abstract][Full Text] [Related]
2. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
3. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
4. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
[TBL] [Abstract][Full Text] [Related]
5. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
6. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.
Chen RX; Xia YH; Xue TC; Ye SL
J Exp Clin Cancer Res; 2010 Dec; 29(1):172. PubMed ID: 21190594
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin regulates epithelial mesenchymal transition-associated growth of hepatocellular cancer in a mouse xenograft model.
Bhattacharya SD; Mi Z; Kim VM; Guo H; Talbot LJ; Kuo PC
Ann Surg; 2012 Feb; 255(2):319-25. PubMed ID: 22241292
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma.
Gao X; Sheng Y; Yang J; Wang C; Zhang R; Zhu Y; Zhang Z; Zhang K; Yan S; Sun H; Wei J; Wang X; Yu X; Zhang Y; Luo Q; Zheng Y; Qiao P; Zhao Y; Dong Q; Qin L
J Exp Clin Cancer Res; 2018 Jul; 37(1):179. PubMed ID: 30064482
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
Cao L; Fan X; Jing W; Liang Y; Chen R; Liu Y; Zhu M; Jia R; Wang H; Zhang X; Zhang Y; Zhou X; Zhao J; Guo Y
Oncotarget; 2015 Mar; 6(9):6627-40. PubMed ID: 25749383
[TBL] [Abstract][Full Text] [Related]
11. A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase.
Zhang X; Ye LH; Zhang XD
Acta Pharmacol Sin; 2010 May; 31(5):593-600. PubMed ID: 20364155
[TBL] [Abstract][Full Text] [Related]
12. [Identification of metastasis-related osteopontin expression and glycosylation in hepatocellular carcinoma].
Sun HY; Li Y; Guo K; Kang XN; Sun C; Liu YK
Zhonghua Gan Zang Bing Za Zhi; 2011 Dec; 19(12):904-7. PubMed ID: 22525502
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells.
Liu G; Fan X; Tang M; Chen R; Wang H; Jia R; Zhou X; Jing W; Wang H; Yang Y; Yin F; Wei H; Li B; Zhao J
Cancer Lett; 2016 Dec; 383(2):171-182. PubMed ID: 27702661
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-dependent osteopontin expression induces metastatic behavior in HepG2 cells.
Guo H; Marroquin CE; Wai PY; Kuo PC
Dig Dis Sci; 2005 Jul; 50(7):1288-98. PubMed ID: 16047475
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma.
Liu W; Xu G; Ma J; Jia W; Li J; Chen K; Wang W; Hao C; Wang Y; Wang X
Tohoku J Exp Med; 2011 May; 224(1):29-39. PubMed ID: 21512310
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin splice variants differentially modulate the migratory activity of hepatocellular carcinoma cell lines.
Chae S; Jun HO; Lee EG; Yang SJ; Lee DC; Jung JK; Park KC; Yeom YI; Kim KW
Int J Oncol; 2009 Dec; 35(6):1409-16. PubMed ID: 19885563
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes.
Iqbal J; McRae S; Banaudha K; Mai T; Waris G
J Biol Chem; 2013 Dec; 288(52):36994-7009. PubMed ID: 24240095
[TBL] [Abstract][Full Text] [Related]
19. Luteolin induces caspase-dependent apoptosis via inhibiting the AKT/osteopontin pathway in human hepatocellular carcinoma SK-Hep-1 cells.
Im E; Yeo C; Lee EO
Life Sci; 2018 Sep; 209():259-266. PubMed ID: 30107166
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin.
Dong Q; Zhu X; Dai C; Zhang X; Gao X; Wei J; Sheng Y; Zheng Y; Yu J; Xie L; Qin Y; Qiao P; Zhou C; Yu X; Jia H; Ren N; Zhou H; Ye Q; Qin L
Oncotarget; 2016 Mar; 7(11):12997-3012. PubMed ID: 26824421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
